Bellevue Group Ag

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 177Value: $4.5BLatest: 2025Q1

Bellevue Group AG is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 177 holdings worth $4.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "AXSM",
  "ASND",
  "EWTX",
  "INSM",
  "KRYS",
  "NAMS",
  "ARQT",
  "RVMD",
  "TEM",
  "ARGX",
  "INSP",
  "NEO",
  "GDX",
  "MASI",
  "EXAS",
  "HUM",
  "MDGL",
  "ABT",
  "ABBV",
  "A",
  "GOOGL",
  "PTCT",
  "PRCT",
  "ALNY",
  "ADMA",
  "EVH",
  "BIDU",
  "BSX",
  "EHC",
  "RXRX",
  "PRVA",
  null,
  "ANNX",
  "ALT",
  "GPCR",
  "RLAY",
  "TVTX",
  "SMMT",
  "MLYS",
  "LEGN",
  "GILD",
  null,
  "BTSG",
  "AZN",
  "QCOM",
  "SRRK",
  "ISRG",
  "NBIX",
  "MGNX",
  null,
  "SIBN",
  "WAY",
  "IQV",
  "IONS",
  "EXEL",
  "PODD",
  "TXG",
  "MDT",
  "MSFT",
  "DOCS",
  "ESPR",
  "INCY",
  "HOLX",
  "TEVA",
  "ILMN",
  "ORCL",
  "UNH",
  "SPY",
  "NVDA",
  "GEHC",
  "PFE",
  "MRK",
  "AMGN",
  "REGN",
  "TMDX",
  "SYK",
  "CI",
  "TMO",
  "PTGX",
  "AGIO",
  "PHR",
  "MRNA",
  "RYTM",
  "MLTX",
  null,
  "ACLX",
  "QURE",
  "GKOS",
  "MTD",
  "GMED",
  "SNY",
  "RMD",
  "VRTX",
  null,
  "EW",
  "SRPT",
  "PEN",
  "ALGN",
  "THC",
  "NTRA",
  "WVE",
  "CAH",
  "IMCR",
  "IDXX",
  "AMZN",
  "HCA",
  "VRNA",
  "VEEV",
  "ZLAB",
  "GRMN",
  "BIIB",
  "BHVN",
  "RDY",
  "LH",
  "MOH",
  "ZBH",
  "MCK",
  "PCVX",
  "STE",
  "BAX",
  "BDX",
  "BEAM",
  "BRBR",
  null,
  "BDTX",
  "BNTX",
  "BIO",
  "BMRN",
  "BMY",
  "BBIO",
  "BRKR",
  "CDNA",
  "CSTL",
  "CLDX",
  "CNC",
  "CERT",
  "COO",
  "CVS",
  "DHR",
  "CYTK",
  "DXCM",
  "IWM",
  "ELV",
  "JNJ",
  "LLY",
  "ZTS"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 177
Total Value: 4462826678
Accession Number: 0001104659-25-048519
Form Type: 13F-HR
CIK: bellevue-group-ag
Manager Name: Bellevue-Group-Ag

Data Enrichment

97% identified

171 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

177 positions • $4.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 8

Sort by:

ARGENX SE

ARGX|04016X101

Shares:578.9K

Value:$342.6M

% of Portfolio:7.7% ($342.6M/$4.5B)

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:7.9M

Value:$236.9M

% of Portfolio:5.3% ($236.9M/$4.5B)

STRYKER CORP

SYK|863667101

Shares:566.6K

Value:$210.9M

% of Portfolio:4.7% ($210.9M/$4.5B)

INTUITIVE SURGICAL INC

ISRG|46120E602

Shares:425.7K

Value:$210.9M

% of Portfolio:4.7% ($210.9M/$4.5B)

ALNYLAM PHARMACEUTICALS, INC.

ALNY|02043Q107

Shares:768.1K

Value:$207.4M

% of Portfolio:4.6% ($207.4M/$4.5B)

ABBOTT LABORATORIES

ABT|002824100

Shares:1.6M

Value:$206.4M

% of Portfolio:4.6% ($206.4M/$4.5B)

NEUROCRINE BIOSCIENCES INC

NBIX|64125C109

Shares:1.8M

Value:$201.3M

% of Portfolio:4.5% ($201.3M/$4.5B)

VERTEX PHARMACEUTICALS INC / MA

VRTX|92532F100

Shares:413.1K

Value:$200.3M

% of Portfolio:4.5% ($200.3M/$4.5B)

BOSTON SCIENTIFIC CORP

BSX|101137107

Shares:2.0M

Value:$196.8M

% of Portfolio:4.4% ($196.8M/$4.5B)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:4.4M

Value:$154.7M

% of Portfolio:3.5% ($154.7M/$4.5B)

INCYTE CORP

INCY|45337C102

Shares:2.1M

Value:$126.7M

% of Portfolio:2.8% ($126.7M/$4.5B)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:3.5M

Value:$103.0M

% of Portfolio:2.3% ($103.0M/$4.5B)

UNITEDHEALTH GROUP INC

UNH|91324P102

Shares:164.7K

Value:$86.3M

% of Portfolio:1.9% ($86.3M/$4.5B)

Medtronic plc

MDT|G5960L103

Shares:938.4K

Value:$84.3M

% of Portfolio:1.9% ($84.3M/$4.5B)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:2.5M

Value:$80.6M

% of Portfolio:1.8% ($80.6M/$4.5B)

BECTON DICKINSON & CO

BDX|075887109

Shares:344.3K

Value:$78.9M

% of Portfolio:1.8% ($78.9M/$4.5B)

DEXCOM INC

DXCM|252131107

Shares:1.1M

Value:$72.7M

% of Portfolio:1.6% ($72.7M/$4.5B)

INSULET CORP

PODD|45784P101

Shares:271.3K

Value:$71.2M

% of Portfolio:1.6% ($71.2M/$4.5B)

Edwards Lifesciences Corp

EW|28176E108

Shares:972.0K

Value:$70.4M

% of Portfolio:1.6% ($70.4M/$4.5B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:3.1M

Value:$55.7M

% of Portfolio:1.2% ($55.7M/$4.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
ARGENX SE(ARGXcusip04016X101)	578.9K	QoQ -2.41% (-14.3K) YoY -28.62% (-232.1K)	All Managers (Combined)	$342.6M	7.7% ($342.6M/$4.5B)	QoQ -6.08% (-$22.2M) YoY +7.29% (-$23.3M)
IONIS PHARMACEUTICALS INC(IONScusip462222100)	7.9M	QoQ -0.19% (-15.5K) YoY -5.37% (-446.3K)	All Managers (Combined)	$236.9M	5.3% ($236.9M/$4.5B)	QoQ -13.87% (-$38.2M) YoY -34.14% (-$122.9M)
STRYKER CORP(SYKcusip863667101)	566.6K	QoQ +8.95% (+46.6K) YoY +26.09% (+117.3K)	All Managers (Combined)	$210.9M	4.7% ($210.9M/$4.5B)	QoQ +12.64% (+$23.7M) YoY +31.16% (+$50.1M)
INTUITIVE SURGICAL INC(ISRGcusip46120E602)	425.7K	QoQ -8.31% (-38.6K) YoY -37.59% (-256.4K)	All Managers (Combined)	$210.9M	4.7% ($210.9M/$4.5B)	QoQ -13.00% (-$31.5M) YoY -22.55% (-$61.4M)
ALNYLAM PHARMACEUTICALS, INC.(ALNYcusip02043Q107)	768.1K	QoQ -0.27% (-2.1K) YoY -16.34% (-150.1K)	All Managers (Combined)	$207.4M	4.6% ($207.4M/$4.5B)	QoQ +14.43% (-$26.2M) YoY +51.13% (-$70.2M)
ABBOTT LABORATORIES(ABTcusip002824100)	1.6M	QoQ -7.84% (-132.5K) YoY +8.50% (+121.9K)	All Managers (Combined)	$206.4M	4.6% ($206.4M/$4.5B)	QoQ +8.07% (-$15.4M) YoY +26.63% (+$43.4M)
NEUROCRINE BIOSCIENCES INC(NBIXcusip64125C109)	1.8M	QoQ 0.00% (-0) YoY -11.47% (-235.9K)	All Managers (Combined)	$201.3M	4.5% ($201.3M/$4.5B)	QoQ -18.97% (-$47.1M) YoY -29.00% (-$82.3M)
VERTEX PHARMACEUTICALS INC / MA(VRTXcusip92532F100)	413.1K	QoQ -15.25% (-74.4K) YoY -38.23% (-255.7K)	All Managers (Combined)	$200.3M	4.5% ($200.3M/$4.5B)	QoQ +2.02% (-$4.0M) YoY -28.36% (-$79.3M)
BOSTON SCIENTIFIC CORP(BSXcusip101137107)	2.0M	QoQ -8.62% (-184.3K) YoY -38.03% (-1.2M)	All Managers (Combined)	$196.8M	4.4% ($196.8M/$4.5B)	QoQ +3.19% (-$6.1M) YoY -8.73% (-$18.8M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	4.4M	QoQ -0.28% (-12.6K) YoY -13.78% (-699.3K)	All Managers (Combined)	$154.7M	3.5% ($154.7M/$4.5B)	QoQ -19.39% (-$37.2M) YoY -5.41% (-$8.8M)
INCYTE CORP(INCYcusip45337C102)	2.1M	QoQ -3.04% (-65.7K) YoY -2.86% (-61.6K)	All Managers (Combined)	$126.7M	2.8% ($126.7M/$4.5B)	QoQ -15.00% (-$22.4M) YoY +3.24% (-$4.0M)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	3.5M	QoQ 0.00% (-0) YoY -12.25% (-490.9K)	All Managers (Combined)	$103.0M	2.3% ($103.0M/$4.5B)	QoQ -10.83% (-$12.5M) YoY -12.07% (-$14.1M)
UNITEDHEALTH GROUP INC(UNHcusip91324P102)	164.7K	QoQ +3.14% (+5.0K) YoY +10.77% (+16.0K)	All Managers (Combined)	$86.3M	1.9% ($86.3M/$4.5B)	QoQ +6.79% (+$5.5M) YoY +17.27% (+$12.7M)
Medtronic plc(MDTcusipG5960L103)	938.4K	QoQ -10.02% (-104.6K) YoY -6.81% (-68.6K)	All Managers (Combined)	$84.3M	1.9% ($84.3M/$4.5B)	QoQ +1.21% (-$1.0M) YoY -3.91% (-$3.4M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	2.5M	QoQ -0.15% (-3.8K) YoY +15.78% (+341.7K)	All Managers (Combined)	$80.6M	1.8% ($80.6M/$4.5B)	QoQ -25.72% (-$27.9M) YoY +109.59% (+$42.1M)
BECTON DICKINSON & CO(BDXcusip075887109)	344.3K	QoQ +2.00% (+6.8K) YoY -17.17% (-71.4K)	All Managers (Combined)	$78.9M	1.8% ($78.9M/$4.5B)	QoQ +2.98% (+$2.3M) YoY -23.32% (-$24.0M)
DEXCOM INC(DXCMcusip252131107)	1.1M	QoQ +1.82% (-19.1K) YoY -12.86% (-157.1K)	All Managers (Combined)	$72.7M	1.6% ($72.7M/$4.5B)	QoQ -10.58% (-$8.6M) YoY -57.09% (-$96.7M)
INSULET CORP(PODDcusip45784P101)	271.3K	QoQ -15.72% (-50.6K) YoY -7.67% (-22.5K)	All Managers (Combined)	$71.2M	1.6% ($71.2M/$4.5B)	QoQ -15.23% (-$12.8M) YoY +41.46% (-$20.9M)
Edwards Lifesciences Corp(EWcusip28176E108)	972.0K	QoQ -11.46% (-125.9K) YoY -11.89% (-131.2K)	All Managers (Combined)	$70.4M	1.6% ($70.4M/$4.5B)	QoQ -13.31% (-$10.8M) YoY -33.17% (-$35.0M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	3.1M	QoQ 0.00% (-0) YoY +9.83% (-275.0K)	All Managers (Combined)	$55.7M	1.2% ($55.7M/$4.5B)	QoQ -28.17% (-$21.9M) YoY -52.50% (-$61.6M)